An Integrative Approach for Idiopathic Granulomatous Mastitis.
IIGM
Traditional and Complementary Medicine: a Cure for Idiopathic Granulomatous Mastitis?
1 other identifier
observational
30
1 country
1
Brief Summary
Collaboration is established between Turkish Holistic \& Integrative Medicine Association and Traditional \& Complementary Medicine Society of Istanbul Medipol University. Study is carried out on idiopathic granulomatous mastitis patients who are followed in the Breast Clinic at Istanbul Medipol University Hospital for between September 2015 and September 2019. Hirudotherapy and medical cupping therapy were applied as traditional and complementary medicine integratively. Following initial radiological imaging, microbiological- and histological testing, side effects and relapses are analyzed. Follow-up examination is also carried out at the end of the treatment, which consisted of clinical breast exam and radiological imaging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedFirst Submitted
Initial submission to the registry
September 16, 2019
CompletedFirst Posted
Study publicly available on registry
September 19, 2019
CompletedSeptember 19, 2019
September 1, 2019
3 months
September 16, 2019
September 18, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change of Breast Mass Size
Ultrasonic scan at 6 months
Up to 12 months
Change of Breast Mass Size
Ultrasonic scan at 12 months
Up to 48 months
Secondary Outcomes (1)
Change of Breast Mass Size
Up to 48 months
Eligibility Criteria
Patients receiving Traditional and Complementary Medicine (T\&CM) for IGM will be retrospectively analyzed.
You may qualify if:
- IGM patients, either ones newly diagnosed or had previously received different types of treatments, currently refusing conventional treatments with immunosuppressives etc, or/and surgical management, and now und
You may not qualify if:
- Patients currently using any conventional treatment, and/or contraindication to hirudotherapy and cupping.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medipol University
Beykoz, Istanbul, 34810, Turkey (Türkiye)
Biospecimen
Biopsy Samples
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 16, 2019
First Posted
September 19, 2019
Study Start
June 1, 2019
Primary Completion
September 1, 2019
Study Completion
September 1, 2019
Last Updated
September 19, 2019
Record last verified: 2019-09